Knoll Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-8,652
Closed -$5.71M 18
2018
Q2
$5.71M Hold
8,652
4.85% 5
2018
Q1
$8.82M Hold
8,652
9.06% 4
2017
Q4
$10.6M Hold
8,652
9.31% 4
2017
Q3
$1.61M Hold
8,652
1.38% 7
2017
Q2
$1.35M Sell
8,652
-476
-5% -$96.3K 1.79% 9
2017
Q1
$2.19M Hold
9,128
3.3% 6
2016
Q4
$2.49M Hold
9,128
4.37% 7
2016
Q3
$2.08M Sell
9,128
-1,666
-15% -$467K 3.65% 9
2016
Q2
$4.18M Sell
10,794
-500
-4% -$546K 1.35% 5
2016
Q1
$7.62M Hold
11,294
3.1% 3
2015
Q4
$11.9M Hold
11,294
4.4% 2
2015
Q3
$9.79M Hold
11,294
4.16% 2
2015
Q2
$8.1M Hold
11,294
2.61% 3
2015
Q1
$25.5M Hold
11,294
7.43% 2
2014
Q4
$11.6M Buy
11,294
+58
+0.5% +$62K 4.57% 2
2014
Q3
$12M Buy
11,236
+1,355
+14% +$2.28M 4.67% 2
2014
Q2
$24.8M Hold
9,881
11.03% 2
2014
Q1
$18.8M Buy
9,881
+3,124
+46% +$7.39M 9.74% 2
2013
Q4
$14.5M Hold
6,757
7.28% 2
2013
Q3
$15.2M Buy
6,757
+2,395
+55% +$4.63M 8.11% 2
2013
Q2
$7.55M Buy
+4,362
New +$6.93M 5.16% 2

Other funds holding AMPE

Knoll Capital Management's AMPE Position: Q3 2018 in Review

Knoll Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2018, closing a stake of 8,652 shares — an estimated $5.71M sold.

Knoll Capital Management first reported a position in AMPE in Q2 2013 and held it in 21 quarters. The position peaked at $25.5M in Q1 2015. 81 funds tracked by Wall St. Rank hold AMPE as of Q3 2018.

  • Knoll Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Knoll Capital Management sold 8,652 Ampio Pharmaceuticals Inc. shares in Q3 2018, an estimated $5.71M.
  • Knoll Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 21 quarters.
  • Knoll Capital Management's Ampio Pharmaceuticals Inc. position peaked at $25.5M in Q1 2015.
  • 81 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2018.

Based on Knoll Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.